Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126937731 | 12693773 | 1 | I | 20150324 | 20160829 | 20160829 | PER | US-PFIZER INC-2015110241 | PFIZER | 0.00 | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126937731 | 12693773 | 1 | PS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 30 MG, 3X/DAY | U | 21260 | 30 | MG | PROLONGED-RELEASE CAPSULE | TID | |||||
126937731 | 12693773 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 150 MG, 3X/DAY | U | 0 | 150 | MG | TID | ||||||
126937731 | 12693773 | 3 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Oral | 15 MG, 4X/DAY | U | 0 | 15 | MG | QID |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126937731 | 12693773 | Blood pressure increased | |
126937731 | 12693773 | Drug withdrawal syndrome | |
126937731 | 12693773 | Heart rate decreased | |
126937731 | 12693773 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126937731 | 12693773 | 3 | 20141225 | 0 |